Theravida

Please read more about TheraVida,  a clinical stage specialty pharmaceutical company focused on the development of THVD-102 for the treatment of primary focal hyperhidrosis. THVD-102’s systemic approach gives it the unique potential to address patients suffering from both primary focal and secondary generalized hyperhidrosis.